Wells Fargo’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Wells Fargo’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$85.6M	Buy	426,213 +237,629	+126%	+$49.2M	0.02%	698
2025 Q4	$38.9M	Buy	188,584 +4,986	+3%	+$996K	0.01%	1077
2025 Q3	$32.9M	Sell	183,598 -5,519	-3%	-$940K	0.01%	1152
2025 Q2	$30.5M	Sell	189,117 -6,454	-3%	-$1.03M	0.01%	1130
2025 Q1	$33.3M	Buy	195,571 +5,640	+3%	+$980K	0.01%	1004
2024 Q4	$31.6M	Sell	189,931 -251	-0.1%	-$42.9K	0.01%	1055
2024 Q3	$32.7M	Sell	190,182 -182,850	-49%	-$30.3M	0.01%	1002
2024 Q2	$57.4M	Sell	373,032 -57,348	-13%	-$8.61M	0.01%	709
2024 Q1	$66.2M	Buy	430,380 +34,083	+9%	+$5.2M	0.02%	657
2023 Q4	$62.6M	Sell	396,297 -51,049	-11%	-$7.33M	0.02%	644
2023 Q3	$65.5M	Buy	447,346 +1,529	+0.3%	+$233K	0.02%	575
2023 Q2	$68.3M	Sell	445,817 -71,083	-14%	-$11.1M	0.02%	587
2023 Q1	$80.1M	Buy	516,900 +12,233	+2%	+$1.92M	0.02%	514
2022 Q4	$77.8M	Sell	504,667 -29,661	-6%	-$4.38M	0.02%	512
2022 Q3	$70.5M	Buy	534,328 +23,169	+5%	+$3.25M	0.02%	519
2022 Q2	$69.3M	Sell	511,159 -33,847	-6%	-$4.67M	0.02%	533
2022 Q1	$81.3M	Buy	545,006 +20,554	+4%	+$3.04M	0.02%	563
2021 Q4	$84.9M	Sell	524,452 -71,505	-12%	-$11.6M	0.02%	551
2021 Q3	$99M	Sell	595,957 -42,112	-7%	-$7.19M	0.02%	665
2021 Q2	$110M	Buy	638,069 +27,332	+4%	+$4.51M	0.02%	631
2021 Q1	$98M	Sell	610,737 -10,182	-2%	-$1.74M	0.02%	682
2020 Q4	$104M	Sell	620,919 -123,391	-17%	-$20M	0.03%	623
2020 Q3	$117M	Sell	744,310 -18,391	-2%	-$3.01M	0.03%	500
2020 Q2	$128M	Buy	762,701 +111,055	+17%	+$17.4M	0.04%	441
2020 Q1	$85.4M	Sell	651,646 -118,557	-15%	-$16.9M	0.03%	522
2019 Q4	$115M	Sell	770,203 -20,115	-3%	-$2.76M	0.03%	537
2019 Q3	$97.8M	Sell	790,318 -457,111	-37%	-$60.8M	0.03%	574
2019 Q2	$176M	Sell	1,247,429 -150,859	-11%	-$20.8M	0.05%	375
2019 Q1	$211M	Buy	1,398,288 +334,286	+31%	+$48.1M	0.06%	308
2018 Q4	$132M	Sell	1,064,002 -13,015	-1%	-$1.78M	0.04%	417
2018 Q3	$171M	Buy	1,077,017 +342,939	+47%	+$51.9M	0.05%	396
2018 Q2	$103M	Buy	734,078 +88,947	+14%	+$12.2M	0.03%	564
2018 Q1	$85.7M	Buy	645,131 +117,250	+22%	+$16M	0.03%	635
2017 Q4	$65.8M	Buy	527,881 +76,218	+17%	+$9.42M	0.02%	748
2017 Q3	$56M	Buy	451,663 +34,522	+8%	+$4.09M	0.02%	811
2017 Q2	$47.6M	Buy	417,141 +27,447	+7%	+$2.95M	0.02%	887
2017 Q1	$41M	Sell	389,694 -31,930	-8%	-$3.2M	0.01%	950
2016 Q4	$38.3M	Sell	421,624 -15,902	-4%	-$1.49M	0.01%	961
2016 Q3	$43.6M	Buy	437,526 +50,383	+13%	+$4.94M	0.02%	848
2016 Q2	$34.6M	Sell	387,143 -71,931	-16%	-$6.61M	0.01%	949
2016 Q1	$40.2M	Sell	459,074 -1,448,205	-76%	-$128M	0.02%	876
2015 Q4	$216M	Buy	1,907,279 +46,502	+2%	+$5.01M	0.09%	270
2015 Q3	$189M	Sell	1,860,777 -187,051	-9%	-$22.2M	0.08%	286
2015 Q2	$254M	Sell	2,047,828 -103,313	-5%	-$12.5M	0.1%	241
2015 Q1	$254M	Buy	2,151,141 +172,553	+9%	+$19.5M	0.1%	237
2014 Q4	$202M	Buy	1,978,588 +288,761	+17%	+$28.2M	0.08%	289
2014 Q3	$155M	Buy	1,689,827 +132,691	+9%	+$11.5M	0.07%	339
2014 Q2	$128M	Sell	1,557,136 -60,309	-4%	-$4.61M	0.05%	396
2014 Q1	$124M	Sell	1,617,445 -10,950	-0.7%	-$854K	0.05%	400
2013 Q4	$113M	Buy	1,628,395 +136,877	+9%	+$8.98M	0.05%	411
2013 Q3	$96.6M	Buy	1,491,518 +400,443	+37%	+$25.3M	0.05%	423
2013 Q2	$63.5M	Buy	+1,091,075	New	+$62.3M	0.03%	545

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.28B AUM 27.63% 1-Year Est. Return

Wells Fargo's FBT Position: Q1 2026 in Review

Wells Fargo increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 126% in Q1 2026, buying an estimated $49.2M and bringing the position to 426,213 shares worth $85.6M. The position accounts for 0.02% of the portfolio, ranked #698.

Wells Fargo first reported a position in FBT in Q2 2013 and has held it in 52 quarters since. The position peaked at $254M in Q1 2015. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Wells Fargo held 426,213 shares of First Trust NYSE Arca Biotechnology Index Fund worth $85.6M as of Q1 2026.
Wells Fargo bought 237,629 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $49.2M.
First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Wells Fargo's portfolio in Q1 2026, its #698 holding.
Wells Fargo first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 52 quarters since.
Wells Fargo's First Trust NYSE Arca Biotechnology Index Fund position peaked at $254M in Q1 2015.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.